Merck, Roche, AstraZeneca, and Lilly all rose in the rankings with Lilly pushing GSK out of the top 10
Alternative GLP-1 formulations, dose adjustments, or switching to different weight loss medications may be appropriate
Everyones GLP-1 experience is personal
Reduced Eating Frequency Patients using GLP-1s for chronic weight management commonly eat less and may eat less frequently
Top Product Forecasts for 2024 [1] NO
Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare : Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations